Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloperidone vs Risperidone in Schizophrenia
NCT01623713Phase 2Completed
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Jun 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iloperidone in schizophrenia, sponsored by Hansoh Pharmaceutical Group. Started Jun 2012; status: completed.
02
Drugs
iloperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01623713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623713.